Refresh LACRI-LUBE — Class II drug recall D-0665-2024
Ongoing recall by AbbVie Inc., reported 2024-10-02, distributed nationwide. Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
| Recall number | D-0665-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | AbbVie Inc., North Chicago, IL, United States |
| Recall initiated | 2024-09-16 |
| Classified | 2024-09-23 |
| Reported by FDA | 2024-10-02 |
| Distributed | Nationwide (US) |
| Countries outside the US | CA, GB |
| Quantity | 763,426 tubes |
| Reason classes | sterility, packaging |
| UPC / GTIN / UDI-DI | 00300230312042 |
| Lot numbers | 387489, 387490, 390422, 390424, 391692, 391893, 394822, 395991, 397905, 397973, 397974, 399019, 399254, 399922, 408738, T3911, T4015, T4031, T4032, T4033, T4108 |
Product
Refresh LACRI-LUBE, (42.5% Mineral Oil, 57.3% White Petrolatum) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, Distributed by: Allergen, an AbbVie company, Madison, NJ 07940, UPC code: 300230312042
Reason for recall
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0665-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.